{"id":"https://openalex.org/W1980644232","doi":"https://doi.org/10.1158/1538-7445.am2014-148","title":"Abstract 148: Release of the TNF-family member BAFF by NK cells contributes to the resistance of chronic lymphoid leukemia cells to direct and Rituximab-induced NK reactivity","display_name":"Abstract 148: Release of the TNF-family member BAFF by NK cells contributes to the resistance of chronic lymphoid leukemia cells to direct and Rituximab-induced NK reactivity","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W1980644232","doi":"https://doi.org/10.1158/1538-7445.am2014-148","mag":"1980644232"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-148","doi":"https://doi.org/10.1158/1538-7445.am2014-148","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-148","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018715398","display_name":"Julia S Wild","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Wild","raw_affiliation_strings":["1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071199486","display_name":"Benjamin Joachim Schmiedel","orcid":"https://orcid.org/0000-0002-9103-9378","observed_orcids":["https://orcid.org/0000-0002-9103-9378"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Benjamin J. Schmiedel","raw_affiliation_strings":["1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020683761","display_name":"Andreas Maurer","orcid":"https://orcid.org/0000-0003-2412-5361","observed_orcids":["https://orcid.org/0000-0003-2412-5361"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Maurer","raw_affiliation_strings":["2Interfaculty Institute of Biochemistry, Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Interfaculty Institute of Biochemistry, Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112094075","display_name":"Stefanie Raab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefanie Raab","raw_affiliation_strings":["1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045281805","display_name":"Pascal Schneider","orcid":"https://orcid.org/0000-0003-0677-9409","observed_orcids":["https://orcid.org/0000-0003-0677-9409"]},"institutions":[{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Pascal Schneider","raw_affiliation_strings":["3Department of Biochemistry, University of Lausanne, Lausanne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Biochemistry, University of Lausanne, Lausanne, Switzerland","institution_ids":["https://openalex.org/I97565354"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026255080","display_name":"Helmut Rainer Salih","orcid":"https://orcid.org/0000-0002-6719-1847","observed_orcids":["https://orcid.org/0000-0002-6719-1847"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Helmut R. Salih","raw_affiliation_strings":["1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"148","last_page":"148"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.04349999874830246,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.796999990940094},{"id":"https://openalex.org/keywords/b-cell-activating-factor","display_name":"B-cell activating factor","score":0.7839999794960022},{"id":"https://openalex.org/keywords/baff","display_name":"BAFF","score":0.847000002861023},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9959999918937683},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":0.9039999842643738},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8259999752044678},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.9480000138282776},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/nk-cell-mediated-lysis","display_name":"NK cell-mediated lysis","score":0.6209999918937683},{"id":"https://openalex.org/keywords/b-cell-metabolism","display_name":"B cell metabolism","score":0.47099998593330383},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tnf-family-cytokines","display_name":"TNF family cytokines","score":0.7250000238418579},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.8496829867362976},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8170878291130066},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5359946489334106},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5344340801239014},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5339528322219849},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48192477226257324},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4424748718738556},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.41794389486312866},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3763822615146637},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.3581596612930298},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3217240571975708},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.26163095235824585},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.15300729870796204},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10285276174545288},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-148","doi":"https://doi.org/10.1158/1538-7445.am2014-148","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-148","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2590027025","https://openalex.org/W2095278781","https://openalex.org/W2793090284","https://openalex.org/W2585963519","https://openalex.org/W2068335535","https://openalex.org/W2555185508","https://openalex.org/W2465669814","https://openalex.org/W4313373532","https://openalex.org/W2570827801","https://openalex.org/W4295908375"],"abstract_inverted_index":{"Abstract":[0],"NK":[1,25,57,123,158,170,242,280,291,312,366,381],"cells":[2,26,58,62,124,186,231,254,275,292,313,367,376],"are":[3,7,78],"cytotoxic":[4],"lymphocytes":[5],"that":[6,53,96,122,169],"particularly":[8],"important":[9],"for":[10,206,337,395],"the":[11,30,44,54,75,87,100,128,133,140,174,199,207,217,226,229,264,270,287,307,361,370,387,392],"immunosurveillance":[12],"of":[13,33,46,56,104,177,209,221,228,266,273,290,311,330,339,360,372,386,391],"leukemia.":[14],"Due":[15],"to":[16,19,29,59,64,109,116,215,224,232,238,268,279,293,298,314,326,369,377],"their":[17,277],"ability":[18,55,289,310],"mediate":[20,65,315],"antibody-dependent":[21],"cellular":[22],"cytotoxicity":[23,259,282],"(ADCC),":[24],"substantially":[27,239],"contribute":[28],"therapeutic":[31],"benefit":[32,329],"antitumor":[34],"antibodies":[35],"like":[36],"Rituximab,":[37],"which":[38,114,203],"is":[39,67,204],"a":[40,112,136,161,327],"crucial":[41],"component":[42],"in":[43,69,135,249,286,320],"treatment":[45,193,208,319],"B":[47,91,105,340],"cell":[48,92,189,243,281,341],"malignancies.":[49,342],"Available":[50],"data":[51,262],"indicate":[52],"target":[60],"malignant":[61],"and":[63,102,131,196,223,245,276,306,335,379],"ADCC":[66,248,316],"compromised":[68,288],"Chronic":[70],"Lymphoid":[71],"Leukemia":[72],"(CLL),":[73],"but":[74],"underlying":[76],"mechanisms":[77],"still":[79],"unclear":[80],"(Jaglowski":[81],"et":[82,302],"al.,":[83,303],"Blood":[84,304],"2010).":[85],"With":[86],"TNF":[88],"family":[89],"member":[90,363],"activating":[93],"factor":[94,113],"(BAFF)":[95],"regulates,":[97],"among":[98],"others,":[99],"proliferation":[101],"survival":[103],"cells,":[106],"we":[107,167],"believe":[108],"have":[110],"identified":[111],"contributes":[115,368],"these":[117],"clinical":[118],"observations.":[119],"We":[120],"report":[121],"express":[125],"BAFF":[126,148,172,183,222,235,267,364],"on":[127,143,154,263],"mRNA":[129],"level":[130],"release":[132],"protein":[134],"soluble":[137],"form":[138],"with":[139,194,251],"levels":[141],"depending":[142],"activation":[144],"state.":[145],"Notably,":[146,198],"relevant":[147],"surface":[149],"expression":[150],"was":[151,213,236],"neither":[152],"detected":[153],"resting":[155],"nor":[156],"activated":[157],"cells.":[159,180],"Using":[160],"tetrazolium":[162],"salt":[163],"based":[164],"colorimetric":[165],"assay":[166],"found":[168,214,237],"cell-derived":[171],"enhances":[173],"metabolic":[175,271],"activity":[176,272],"primary":[178,252],"CLL":[179,185,253],"In":[181],"addition,":[182],"protects":[184],"from":[187],"chemotherapy-induced":[188],"death":[190],"e.g.":[191],"upon":[192,317],"Fludarabine":[195],"Cyclophosphamide.":[197],"BAFF-specific":[200],"antibody":[201],"Belimumab,":[202],"approved":[205],"systemic":[210],"lupus":[211],"erythematosus,":[212],"block":[216],"leukemia":[218,230,375],"cell-protective":[219],"effects":[220],"restore":[225],"sensitivity":[227],"chemotherapy.":[233],"Furthermore,":[234,322],"reduce":[240],"direct":[241,378],"lysis":[244],"also":[246],"Rituximab-mediated":[247],"cultures":[250],"as":[255,296],"measured":[256],"by":[257,365],"Europium":[258],"assays.":[260],"Our":[261],"capacity":[265],"enhance":[269],"B-CLL":[274],"resistance":[278,371],"suggest":[283],"its":[284],"involvement":[285],"combat":[294],"lymphoid":[295,374],"compared":[297],"myeloid":[299],"leukemias":[300],"(Pende":[301],"2005)":[305],"reportedly":[308],"impaired":[309],"Rituximab":[318,334],"CLL.":[321],"our":[323],"findings":[324],"point":[325],"possible":[328],"combinatory":[331],"approaches":[332],"employing":[333],"Belimumab":[336],"immunotherapy":[338],"Citation":[343],"Format:":[344],"Julia":[345],"Wild,":[346],"Benjamin":[347],"J.":[348],"Schmiedel,":[349],"Andreas":[350],"Maurer,":[351],"Stefanie":[352],"Raab,":[353],"Pascal":[354],"Schneider,":[355],"Helmut":[356],"R.":[357],"Salih.":[358],"Release":[359],"TNF-family":[362],"chronic":[373],"Rituximab-induced":[380],"reactivity.":[382],"[abstract].":[383],"In:":[384],"Proceedings":[385],"105th":[388],"Annual":[389],"Meeting":[390],"American":[393],"Association":[394],"Cancer":[396,407],"Research;":[397],"2014":[398],"Apr":[399],"5-9;":[400],"San":[401],"Diego,":[402],"CA.":[403],"Philadelphia":[404],"(PA):":[405],"AACR;":[406],"Res":[408],"2014;74(19":[409],"Suppl):Abstract":[410],"nr":[411],"148.":[412],"doi:10.1158/1538-7445.AM2014-148":[413]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}